Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Arcutis Biotherapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 188
- +3 vs. Q2 2024
- Shares held
- 128.6M
- +10.8M (+9.1%) vs. Q2 2024
- Total value
- $1.20B
- +$101.8M (+9.3%) vs. Q2 2024
- New holders
- 34
- 72 more added
- Sold out
- 31
- 48 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Legato Capital Management LLC | 56,208 | $522.7K | 0.06% | 00.0% | Unchanged |
| Corebridge Financial, Inc. | 56,805 | $528.3K | 0.00% | −351−0.6% | Reduced |
| PEAK6 Investments LLC | 60,000 | $558.0K | 0.03% | −10,000−14.3% | Reduced |
| Price T Rowe Associates Inc | 60,148 | $560.0K | 0.00% | +1,246+2.1% | Added |
| MetLife Investment Management | 61,658 | $573.4K | 0.00% | 00.0% | Unchanged |
| Close Asset Management Ltd | 64,774 | $602.0K | 0.02% | 00.0% | Unchanged |
| Mirae Asset Global ETFs Holdings Ltd. | 69,369 | $645.8K | 0.00% | +18,925+37.5% | Added |
| Algert Global LLC | 72,480 | $674.1K | 0.02% | +62,065+595.9% | Added |
| Squarepoint Ops LLC | 72,623 | $675.4K | 0.00% | +72,623 | New |
| Campbell & CO Investment Adviser LLC | 75,548 | $702.6K | 0.05% | +12,455+19.7% | Added |
| Stonepine Capital Management, LLC | 88,457 | $822.6K | 0.52% | +88,457 | New |
| Capula Management Ltd | 88,723 | $825.1K | 0.01% | +88,723 | New |
| Ameriprise Financial Inc | 89,267 | $830.2K | 0.00% | +11,861+15.3% | Added |
| Citigroup Inc | 89,622 | $833.5K | 0.00% | +35,023+64.1% | Added |
| Trexquant Investment LP | 90,204 | $838.9K | 0.01% | −577,055−86.5% | Reduced |
| UBS Oconnor LLC | 92,019 | $855.8K | 0.02% | +92,019 | New |
| California State Teachers Retirement System | 98,654 | $917.5K | 0.00% | −2,648−2.6% | Reduced |
| Jacobs Levy Equity Management, Inc | 100,172 | $931.6K | 0.00% | −75,737−43.1% | Reduced |
| Wesbanco Bank Inc | 102,700 | $955.1K | 0.03% | +102,700 | New |
| State of Wisconsin Investment Board | 106,267 | $988.3K | 0.00% | +4,978+4.9% | Added |
| Legal & General Group Plc | 107,976 | $1.00M | 0.00% | +3,585+3.4% | Added |
| Jane Street Group, LLC | 111,072 | $1.03M | 0.00% | −39,033−26.0% | Reduced |
| Alliancebernstein L.P. | 111,160 | $1.03M | 0.00% | 00.0% | Unchanged |
| MYDA Advisors LLC | 120,000 | $1.12M | 0.32% | +45,000+60.0% | Added |
| Los Angeles Capital Management LLC | 125,103 | $1.16M | 0.00% | −10,845−8.0% | Reduced |
| LPL Financial LLC | 126,280 | $1.17M | 0.00% | −23,260−15.6% | Reduced |
| Jefferies Financial Group Inc. | 128,180 | $1.19M | 0.02% | +128,180 | New |
| Voloridge Investment Management, LLC | 128,443 | $1.19M | 0.00% | −434,728−77.2% | Reduced |
| DekaBank Deutsche Girozentrale | 140,000 | $1.34M | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 163,454 | $1.52M | 0.00% | −3,835−2.3% | Reduced |
| Essex Investment Management Co LLC | 163,964 | $1.52M | 0.27% | +403+0.2% | Added |
| FMR LLC | 171,219 | $1.59M | 0.00% | +34,884+25.6% | Added |
| Two Sigma Investments, LP | 173,665 | $1.62M | 0.00% | −460,776−72.6% | Reduced |
| Norges Bank | 174,820 | $1.63M | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 182,800 | $1.70M | 0.00% | −305,800−62.6% | Reduced |
| Renaissance Technologies LLC | 192,099 | $1.79M | 0.00% | +192,099 | New |
| Swiss National Bank | 203,600 | $1.89M | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 220,194 | $2.05M | 0.00% | −89,377−28.9% | Reduced |
| Ami Asset Management Corp | 223,681 | $2.08M | 0.11% | +59,487+36.2% | Added |
| Gsa Capital Partners LLP | 237,174 | $2.21M | 0.17% | +208,599+730.0% | Added |
| Point72 Asset Management, L.P. | 244,386 | $2.27M | 0.01% | +244,386 | New |
| AQR Capital Management LLC | 252,151 | $2.35M | 0.00% | −5,206−2.0% | Reduced |
| Barclays PLC | 253,392 | $2.36M | 0.00% | +151,279+148.1% | Added |
| UBS Asset Management Americas Inc | 276,691 | $2.57M | 0.00% | +2,912+1.1% | Added |
| Rafferty Asset Management, LLC | 276,818 | $2.57M | 0.01% | +17,340+6.7% | Added |
| Bank of New York Mellon Corp | 311,059 | $2.89M | 0.00% | −79,143−20.3% | Reduced |
| Two Seas Capital LP | 312,122 | $2.90M | 0.49% | −450,068−59.0% | Reduced |
| PDT Partners, LLC | 319,715 | $2.97M | 0.26% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 323,701 | $3.01M | 0.03% | −789,881−70.9% | Reduced |
| Fishman Jay A Ltd | 418,000 | $3.89M | 0.39% | +71,400+20.6% | Added |
| Standard Life Aberdeen plc | 482,074 | $4.48M | 0.01% | +333,200+223.8% | Added |
| Federated Hermes, Inc. | 501,831 | $4.67M | 0.01% | +151,717+43.3% | Added |
| Prudential Financial Inc | 572,615 | $5.33M | 0.01% | 00.0% | Unchanged |
| Eversept Partners, LP | 693,263 | $6.45M | 0.49% | −144,584−17.3% | Reduced |
| Deutsche Bank AG | 800,027 | $7.44M | 0.00% | −1,081,998−57.5% | Reduced |
| Lazard Asset Management LLC | 803,204 | $7.47M | 0.01% | +443,207+123.1% | Added |
| Nuveen Asset Management, LLC | 807,650 | $7.51M | 0.00% | +72,608+9.9% | Added |
| Charles Schwab Investment Management Inc | 859,846 | $8.00M | 0.00% | +8,522+1.0% | Added |
| Northern Trust Corp | 936,515 | $8.71M | 0.00% | +184,665+24.6% | Added |
| Invesco Ltd. | 938,484 | $8.73M | 0.00% | +890+0.1% | Added |
| Millennium Management LLC | 1,147,473 | $10.7M | 0.01% | +634,777+123.8% | Added |
| Tejara Capital Ltd | 1,165,309 | $10.8M | 5.17% | −178,300−13.3% | Reduced |
| Bank of America Corp | 1,175,905 | $10.9M | 0.00% | +608,782+107.3% | Added |
| JPMorgan Chase & Co | 1,296,911 | $12.1M | 0.00% | +11,833+0.9% | Added |
| Perceptive Advisors LLC | 1,358,500 | $12.6M | 0.27% | −200,000−12.8% | Reduced |
| Candriam Luxembourg S.C.A. | 1,426,496 | $13.3M | 0.08% | +119,015+9.1% | Added |
| American Century Companies Inc | 1,464,311 | $13.6M | 0.01% | +232,611+18.9% | Added |
| J. Goldman & Co LP | 1,492,217 | $13.9M | 0.60% | +180,668+13.8% | Added |
| Goldman Sachs Group Inc | 1,589,882 | $14.8M | 0.00% | +782,548+96.9% | Added |
| GW&K Investment Management, LLC | 1,593,630 | $14.8M | 0.13% | −74,349−4.5% | Reduced |
| D. E. Shaw & Co., Inc. | 1,745,024 | $16.2M | 0.02% | +737,640+73.2% | Added |
| StemPoint Capital LP | 1,778,318 | $16.5M | 4.96% | +812,926+84.2% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,120,508 | $19.7M | 11.71% | +79,400+3.9% | Added |
| Cormorant Asset Management, LP | 2,325,000 | $21.6M | 1.15% | −200,000−7.9% | Reduced |
| Ensign Peak Advisors, Inc | 2,416,812 | $22.5M | 0.04% | +283,110+13.3% | Added |
| Geode Capital Management, LLC | 2,470,138 | $23.0M | 0.00% | +48,868+2.0% | Added |
| Citadel Advisors LLC | 3,031,073 | $28.2M | 0.03% | +98,426+3.4% | Added |
| Gilder Gagnon Howe & Co LLC | 3,553,838 | $33.1M | 0.40% | −62,694−1.7% | Reduced |
| Morgan Stanley | 3,781,195 | $35.2M | 0.00% | −191,499−4.8% | Reduced |
| Franklin Resources Inc | 4,250,418 | $41.4M | 0.01% | −187,761−4.2% | Reduced |
| State Street Corp | 5,641,631 | $52.5M | 0.00% | +506,788+9.9% | Added |
| Polar Capital Holdings Plc | 6,884,372 | $64.0M | 0.38% | +5,300+0.1% | Added |
| Vanguard Group Inc | 6,962,635 | $64.8M | 0.00% | +818,345+13.3% | Added |
| Frazier Life Sciences Management, L.P. | 8,785,284 | $81.7M | 3.27% | 00.0% | Unchanged |
| BlackRock, Inc. | 9,029,556 | $84.0M | 0.00% | +9,029,556 | New |
| Suvretta Capital Management, LLC | 10,721,511 | $99.7M | 3.58% | +717,019+7.2% | Added |
| Rubric Capital Management LP | 10,966,672 | $102.0M | 1.67% | +1,150,000+11.7% | Added |
| Jennison Associates LLC | 11,663,497 | $108.5M | 0.07% | +91,803+0.8% | Added |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −1,030,703−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −489,642−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −437,362−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −221,697−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Pennant Investors, LP | 0 | $0 | 0.00% | −170,900−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −159,626−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −151,385−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −142,661−100.0% | Sold out |
| J. Safra Sarasin Holding AG | 0 | $0 | 0.00% | −129,560−100.0% | Sold out |
| Colony Group, LLC | 0 | $0 | 0.00% | −63,100−100.0% | Sold out |
| Capital Impact Advisors, LLC | 0 | $0 | 0.00% | −65,147−100.0% | Sold out |